investment analyst coverage
BTIG Initiates Coverage of DermTech With Buy Rating
The investment bank said DermTech's pigmented lesion assay for the early detection of melanoma is well positioned in an estimated $3 billion-plus market.
SVB Leerink, BTIG Initiate Coverage of Olink With Outperform, Buy Ratings
Both firms highlighted the company's proximity extension assay technology and its ability to provide highly multiplexed proteomic analyses.
GenomeWeb Index Falls Again in March, Led by 29 Percent Decline in Adaptive Biotech Stock
The GenomeWeb Index underperformed the Dow Jones and the Nasdaq, but outperformed the Nasdaq Biotechnology Index last month.
Investment Banks Initiate Coverage of Talis Biomedical With Bullish Outlooks
Talis, which went public last month, develops point-of-care infectious disease tests based on its flagship Talis One sample-to-answer platform.
Quidel Stock Plunges in February as GenomeWeb Index Falls 3 Percent
The GenomeWeb Index underperformed the Dow Jones, the Nasdaq, and the Nasdaq Biotechnology Index last month.
Dec 28, 2020
Nov 30, 2020
BTIG Initiates Coverage of Oncocyte With Buy Rating
Nov 23, 2020
Three Investment Banks Initiate Coverage of Biodesix
Nov 5, 2020
Personalis Q3 Revenues Up 16 Percent
Oct 23, 2020
BTIG Initiates Coverage of Progenity With Buy Rating
Oct 14, 2020